The R&D organization drives therapeutic innovation from the lab bench to the patient bedside. It develops DNDi’s portfolio of drug candidates from the onset (with the design of target product profiles) to the end point (enabling patients’ access to the new treatments). With members located in various DNDi offices worldwide, R&D teams are key enablers of DNDi’s virtual research model which relies on collaborative partnerships with industry and science partners worldwide, fully inclusive of LMICs clinicians and researchers. Projects are run by project leaders and team members regrouping needed expertise from all DNDi functions, beyond R&D.
The R&D organization include three clusters of Diseases expert teams: NTD/Mycetoma and Leishmaniasis, NTD/Chagas-Filarial-HAT and Viral Diseases. Integrated Clinical Development Sciences (Drug Safety & Pharmacovigilance, Clinical Quality Assurance and Translational Sciences), Regulatory Sciences, Global Clinical Operations, R&D Portfolio and Planning, Discovery and Pharmaceutical Development teams complement the R&D expertise. Projects review, science and strategy is managed by the Scientific Internal Review Committee (SIRC); The R&D Coordination team lead the R&D organization for all other topics.
Together with more than 200 public research and industry allies worldwide, we use the power of partnership, innovation, open science, and advocacy to find solutions to a great injustice: the lack of medicines for life-threatening diseases that disproportionately impact poor and marginalized people. Driven by collaboration, not competition, and by patients’ needs, not profits, we promote equitable access, foster inclusive and sustainable solutions, and advocate for a more effective global biomedical R&D system that meets the needs of neglected patients.
Location for these roles: Europe or Africa
This portfolio previously known as the “filarial program” has now expanded beyond onchocerciasis and covers other parasitic worms, including schistosomiasis, lymphatic filariasis and soil-transmitted helminths. The expansion of the portfolio prompted a reorganization and strengthening of the programs.
To expand our Parasitic Worms (Helminths) Program further, we are seeking two scientific professionals with complementary expertise to work together in shaping and advancing this critical research area. Together, these roles will form a dynamic and balanced team, ensuring the success of the Parasitic Worms Program by combining strategic oversight, scientific depth, and hands-on research expertise
We are seeking two individuals with distinct yet complementary skills to form a well-rounded program team.
Both these positions will focus on:
Data and Safety Monitoring Board (DSMB):
Support and enable review of projects by:
As Members of the Core Management Team and the Medical Forum and:
Fundraising, Advocacy and Communication through:
This role has frequent interaction with DNDi staff and external stakeholders to coordinate provision of work or to advocate, persuade and gain support or commitment. This role represents DNDi for a program/service area and develop and maintain relationship with current and future partners.
R& D Technical Skills
DNDi is proud to be an affirmative action and equal opportunity employer. We consider qualified applicants without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, marital status, pregnancy, sex, gender expression or identity, sexual orientation, citizenship, or any other attribute protected by appliable law. DNDi is committed to fostering an inclusive and accessible workplace where everyone has the opportunity to be successful. Our values reflect who we are and who we aspire to be.